Sage Therapeutics Inc. sell Bank of America Co.
Start price
11.03.25
/
50%
€6.76
Target price
11.03.26
€4.61
Performance (%)
12.51%
End price
12.03.26
-
Summary
This prediction is currently being closed. The prediction currently has a disappointing performance of 12.51%. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) is now covered by analysts at Bank of America Co.. They set an "underperform" rating and a $5.00 price target on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Bank_of_America_Co_ for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.99
09.10.24
09.10.24
€5.48
09.10.25
09.10.25
26.80%
10.10.25
10.10.25

